Log in

NASDAQ:APEN - Apollo Endosurgery Stock Price, Forecast & News

$2.04
-0.13 (-5.98 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
$2.01
Now: $2.04
$2.04
50-Day Range
$1.29
MA: $2.50
$3.20
52-Week Range
$1.24
Now: $2.04
$4.08
Volume443 shs
Average Volume9,434 shs
Market Capitalization$42.81 million
P/E RatioN/A
Dividend YieldN/A
Beta0.81
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. Its products include OverStitch and OverStitch Sx Endoscopic Suturing System that enables advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope; Orbera365 Managed Weight Loss System; and the BIB for the treatment of overweight and obese adults. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Read More
Apollo Endosurgery logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APEN
CUSIPN/A
Phone512-279-5100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$60.85 million
Book Value$1.32 per share

Profitability

Net Income$-45,790,000.00

Miscellaneous

Employees215
Market Cap$42.81 million
Next Earnings Date3/30/2020 (Estimated)
OptionableNot Optionable

Receive APEN News and Ratings via Email

Sign-up to receive the latest news and ratings for APEN and its competitors with MarketBeat's FREE daily newsletter.


Apollo Endosurgery (NASDAQ:APEN) Frequently Asked Questions

How has Apollo Endosurgery's stock been impacted by COVID-19 (Coronavirus)?

Apollo Endosurgery's stock was trading at $2.0650 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, APEN stock has decreased by 1.0% and is now trading at $2.0443. View which stocks have been mosted impacted by Coronavirus.

When is Apollo Endosurgery's next earnings date?

Apollo Endosurgery is scheduled to release its next quarterly earnings announcement on Monday, March 30th 2020. View our earnings forecast for Apollo Endosurgery.

How were Apollo Endosurgery's earnings last quarter?

Apollo Endosurgery Inc (NASDAQ:APEN) issued its quarterly earnings results on Thursday, March, 26th. The biotechnology company reported ($0.34) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.38) by $0.04. Apollo Endosurgery had a negative net margin of 71.59% and a negative return on equity of 176.86%. View Apollo Endosurgery's earnings history.

Has Apollo Endosurgery been receiving favorable news coverage?

News headlines about APEN stock have been trending somewhat negative this week, InfoTrie reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Apollo Endosurgery earned a coverage optimism score of -1.5 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an effect on the stock's share price in the near future. View the latest news aboutApollo Endosurgery.

Are investors shorting Apollo Endosurgery?

Apollo Endosurgery saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 181,900 shares, an increase of 31.7% from the February 13th total of 138,100 shares. Based on an average trading volume of 14,700 shares, the days-to-cover ratio is presently 12.4 days. Currently, 1.5% of the company's shares are short sold. View Apollo Endosurgery's Current Options Chain.

Who are some of Apollo Endosurgery's key competitors?

What other stocks do shareholders of Apollo Endosurgery own?

Who are Apollo Endosurgery's key executives?

Apollo Endosurgery's management team includes the following people:
  • Mr. Todd Newton, CEO & Director (Age 56)
  • Dr. Sergey Kantsevoy M.D., Co-Founder and Innovation Partner
  • Mr. Anthony Kalloo M.D., Co-Founder and Innovation Partner
  • Dr. Robert Hawes M.D., Co-Founder and Innovation Partner
  • Dr. Peter Benjamin Cotton M.D., Co-Founder and Innovation Partner

What is Apollo Endosurgery's stock symbol?

Apollo Endosurgery trades on the NASDAQ under the ticker symbol "APEN."

Who are Apollo Endosurgery's major shareholders?

Apollo Endosurgery's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Gagnon Securities LLC (4.77%), Renaissance Technologies LLC (0.41%), Russell Investments Group Ltd. (0.36%) and University of Texas Texas AM Investment Managment Co. (0.07%). Company insiders that own Apollo Endosurgery stock include Matthew S Crawford, Stefanie L Cavanaugh, Stonepine Capital, LP and Todd Newton. View institutional ownership trends for Apollo Endosurgery.

Which institutional investors are selling Apollo Endosurgery stock?

APEN stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd.. View insider buying and selling activity for Apollo Endosurgery.

Which institutional investors are buying Apollo Endosurgery stock?

APEN stock was acquired by a variety of institutional investors in the last quarter, including Gagnon Securities LLC, University of Texas Texas AM Investment Managment Co., and Renaissance Technologies LLC. Company insiders that have bought Apollo Endosurgery stock in the last two years include Matthew S Crawford, Stefanie L Cavanaugh, Stonepine Capital, LP, and Todd Newton. View insider buying and selling activity for Apollo Endosurgery.

How do I buy shares of Apollo Endosurgery?

Shares of APEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Apollo Endosurgery's stock price today?

One share of APEN stock can currently be purchased for approximately $2.04.

How big of a company is Apollo Endosurgery?

Apollo Endosurgery has a market capitalization of $42.81 million and generates $60.85 million in revenue each year. The biotechnology company earns $-45,790,000.00 in net income (profit) each year or ($1.92) on an earnings per share basis. Apollo Endosurgery employs 215 workers across the globe. View additional information about Apollo Endosurgery.

What is Apollo Endosurgery's official website?

The official website for Apollo Endosurgery is http://www.apolloendo.com/.

How can I contact Apollo Endosurgery?

Apollo Endosurgery's mailing address is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. The biotechnology company can be reached via phone at 512-279-5100 or via email at [email protected]


MarketBeat Community Rating for Apollo Endosurgery (NASDAQ APEN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  214 (Thanks for Voting!)
Underperform Votes:  182 (Thanks for Voting!)
Total Votes:  396
MarketBeat's community ratings are surveys of what our community members think about Apollo Endosurgery and other stocks. Vote "Outperform" if you believe APEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel